Hivih
Records under this name other than patents Hivih holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Hivih
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,260,395 | Inhibitors of viral replication, their process of preparation and their therapeutical uses Lapsed on the fee record Ended Feb 16, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2024 | From the USPTO record |
| US 9,238,026 | Inhibitors of viral replication, their process of preparation and their therapeutical uses Lapsed on the fee record Ended Jan 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2024 | From the USPTO record |
| US 7,763,254 | Human Immunodeficiency Virus Integrase-Ledgf P75 Isoform Protein-Protein Interactions. Lapsed on the fee record Ended Jul 27, 2022 · High confidence | Lapsed on the fee record | Ended Jul 27, 2022 | High confidence |
| US 9,994,509 | Inhibitors of viral replication, their process of preparation and their therapeutical uses Lapsed on the fee record Ended Jun 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2022 | From the USPTO record |
| US 9,604,900 | Inhibitors of viral replication, their process of preparation and their therapeutical uses Lapsed on the fee record Ended Mar 28, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 28, 2021 | From the USPTO record |
| US 9,562,033 | Inhibitors of viral replication, their process of preparation and their therapeutical uses Lapsed on the fee record Ended Feb 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 7, 2021 | From the USPTO record |
| US 9,475,802 | Inhibitors of viral replication, their process of preparation and their therapeutical uses Lapsed on the fee record Ended Oct 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 25, 2020 | From the USPTO record |